| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |